- ASCO ‘26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer<p>At the year’s biggest cancer meeting, a high-stakes clash between two popular drug classes erupted, and scientists made headway against a once-insurmountable foe.</p>BioPharma Dive · 1mo ago↗ source
- Obesity care startup Ilant Health raises $15MIlant Health has raised $15 million in a Series A funding round to expand its personalized approach to treating obesity. Ilant is one of many virtual care companies competing to help employers an…Endpoints · 1mo ago↗ source
- Why US-manufactured pharmaceutical packaging equipment matters<p>As manufacturers modernize operations, the origin of their equipment is a strategic consideration.</p>BioPharma Dive · 1mo ago